The effects of different anesthetics on visual evoked potentials during pituitary adenoma resection

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200056803

Enrollment

Unknown

Registered

2022-02-17

Start date

2022-02-21

Completion date

Unknown

Last updated

2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pituitary adenoma

Interventions

remimazolam group:remimazolam

propofol group:propofol

sevoflurane group: sevoflurane

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. ASA I-III, aged >=18 years; 2. For patients who are scheduled for pituitary tumor resection (and need other electrophysiological monitoring), sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe liver and kidney function diseases; 2. Patients with uncontrolled hypertension, diabetes, severe arrhythmia, or unstable angina pectoris; 3. Mentally ill or unable to communicate; 4. History of analgesic abuse and drug use; 5. Silicone allergy; 6. Reject visual evoked potential monitoring.

Design outcomes

Primary

Measure	Time frame
N145 - P100 amplitude;latencies of N145-P100;	—

Secondary

Measure	Time frame
BIS values;blood pressure;heart rate;body temperature;	—

Countries

China

Contacts

Public ContactXie Guannan

Liaocheng People's Hospital

nan5253@163.com+86 18006350080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026